Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice Mounjaro starting to work within the first one to two weeks, though meaningful, visible weight loss typically takes four to twelve weeks to become apparent. Tirzepatide acts on two gut-hormone receptors simultaneously, which slows gastric emptying and reduces appetite — but the body adjusts gradually, and the timeline differs from person to person. As a prescription-only medicine, Mounjaro requires clinical assessment before it can be prescribed; a prescriber decides whether it is suitable for you and at what pace your dose progresses.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Yes, though not always in the way people expect. The most common early signal is a quieter appetite. Food feels less urgent, portions that once felt small start to feel sufficient, and the mental pull toward snacking tends to ease. Some people notice this within three to five days of their first injection; others take two to three weeks. What most people do not see in those early weeks is dramatic weight loss on the scales, and that gap between feeling different and the number moving is where a lot of unnecessary disappointment lives.
The first pen delivers 2.5mg, a dose designed specifically to let your digestive system adjust, not to produce maximum weight reduction. Nausea, the most commonly reported early side effect, is less likely at this stage precisely because the dose is cautious. The first month of tirzepatide treatment is better understood as a settling-in period than a results period. Weight loss during it is a bonus, not the benchmark.
A note on side effects: nausea, mild indigestion and loose stools are common in the early weeks and typically ease within days to a fortnight. They are worth knowing about but rarely a reason to stop, your prescriber can advise if they persist or worsen. The NHS tirzepatide medicines page has a clear breakdown of what to expect and what to watch for.
For most people, the scales start moving meaningfully somewhere between weeks four and eight, often after the first dose increase to 5mg. That is when tirzepatide's dual action on GIP and GLP-1 receptors begins operating at a level where the calorie deficit it creates is large enough to show up consistently. Some people lose a small amount in the first month; others lose very little until the dose steps up. Both are normal.
By weeks twelve to sixteen, when many people have reached 7.5mg or 10mg, the trajectory tends to become clearer. This is usually the phase where the change becomes visible to others and where confidence in the treatment builds. If you are curious how long till Mounjaro starts to work and what the early weeks typically look like, our detailed guide walks through this phase by phase.
The SURMOUNT-1 trial, whose results are reported in the New England Journal of Medicine, followed thousands of adults over 72 weeks. Average weight loss at the 15mg dose reached roughly 20–21% of starting body weight. That figure comes from a full treatment course at a high maintenance dose, not from the first month, context that matters enormously when you are reading your own results in week three.
Titration pace is the biggest variable outside biology. The standard schedule moves through dose increases roughly every four weeks, but prescribers may slow that pace if side effects are troublesome or hold it if a dose increase needs clinical evidence. Rushing ahead is not an option, and nor should it be, the schedule exists for safety and tolerability, not administrative convenience.
Diet matters more than people realise at the start. Mounjaro reduces appetite reliably, but if eating habits remain unchanged the deficit it creates is smaller. Protein adequacy and hydration both affect how the treatment feels day to day; muscle preservation during weight loss is supported by adequate protein and resistance activity, which is worth raising with your prescriber. For a broader view of the treatment, the Mounjaro treatment overview covers the full picture.
Individual biology (gut motility, baseline insulin sensitivity, hormonal factors) genuinely does shift timelines. Two people starting on the same day at the same dose can have notably different week-eight results and both be responding normally. If you want to understand how long before Mounjaro starts working and which biological factors shape that window most, our dedicated guide explores this in detail, and a prescriber who understands your full history is better placed than any general guide to interpret your progress.
If you have been at the highest dose you can tolerate for six months and have lost less than 5% of your starting weight, NICE guidance (TA1026) recommends reviewing whether to continue. That is a clinical decision, not one to reach alone. Short of that threshold, the more useful question is whether your dose is optimised and your lifestyle support is in place, two things a prescriber can assess directly.
Side effects that feel unmanageable, a plateau that worries you, or uncertainty about whether what you're experiencing is normal: all of these are worth raising with your clinical team rather than waiting for a scheduled review. At nume, aftercare is available seven days a week, so questions do not have to wait. People often find it helpful to read up on how long until Mounjaro starts working before their next check-in, so they can frame their progress in context when speaking to their prescriber. If you are still weighing up the treatment options, the weight-loss treatment overview sets out what is currently licensed in the UK and how they compare. When you are ready to have a prescriber look at your situation specifically, you can start a free consultation at any point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.